Bruker Corp (BRKR)
54.49
-1.43
(-2.56%)
USD |
NASDAQ |
Nov 14, 16:00
54.00
-0.49
(-0.90%)
Pre-Market: 08:34
Bruker Cash from Investing (Quarterly): -67.60M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -67.60M |
| June 30, 2024 | -1.325B |
| March 31, 2024 | -304.20M |
| December 31, 2023 | -36.80M |
| September 30, 2023 | -155.00M |
| June 30, 2023 | -26.00M |
| March 31, 2023 | -108.20M |
| December 31, 2022 | -149.30M |
| September 30, 2022 | -57.60M |
| June 30, 2022 | 57.10M |
| March 31, 2022 | -101.80M |
| December 31, 2021 | -48.60M |
| September 30, 2021 | -48.40M |
| June 30, 2021 | -71.40M |
| March 31, 2021 | -24.00M |
| December 31, 2020 | -28.80M |
| September 30, 2020 | -48.20M |
| June 30, 2020 | -15.10M |
| March 31, 2020 | -100.60M |
| December 31, 2019 | -39.20M |
| September 30, 2019 | -12.60M |
| June 30, 2019 | -79.90M |
| March 31, 2019 | -26.70M |
| December 31, 2018 | -156.30M |
| September 30, 2018 | -29.10M |
| Date | Value |
|---|---|
| June 30, 2018 | -46.10M |
| March 31, 2018 | 108.10M |
| December 31, 2017 | 44.50M |
| September 30, 2017 | 47.30M |
| June 30, 2017 | -50.70M |
| March 31, 2017 | -71.30M |
| December 31, 2016 | -40.30M |
| September 30, 2016 | 19.00M |
| June 30, 2016 | 6.90M |
| March 31, 2016 | -7.40M |
| December 31, 2015 | -43.60M |
| September 30, 2015 | -37.30M |
| June 30, 2015 | -15.80M |
| March 31, 2015 | -5.70M |
| December 31, 2014 | -66.20M |
| September 30, 2014 | -52.90M |
| June 30, 2014 | -74.90M |
| March 31, 2014 | -7.90M |
| December 31, 2013 | -8.40M |
| September 30, 2013 | -19.50M |
| June 30, 2013 | -17.80M |
| March 31, 2013 | -14.30M |
| December 31, 2012 | -27.50M |
| September 30, 2012 | -15.30M |
| June 30, 2012 | -17.90M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.325B
Minimum
Jun 2024
57.10M
Maximum
Jun 2022
-134.93M
Average
-53.10M
Median
Cash from Investing (Quarterly) Benchmarks
| Azenta Inc | 201.62M |
| Harvard Bioscience Inc | -1.111M |
| Bionano Genomics Inc | 28.63M |
| Akoya Biosciences Inc | 9.054M |
| Singular Genomics Systems Inc | 23.96M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 38.40M |
| Cash from Financing (Quarterly) | -2.70M |
| Free Cash Flow | 156.70M |
| Free Cash Flow Per Share (Quarterly) | 0.0382 |
| Free Cash Flow to Equity (Quarterly) | -133.10M |
| Free Cash Flow to Firm (Quarterly) | 12.61M |
| Free Cash Flow Yield | 1.94% |